Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Cann Group.
RELATED STOCKHEAD STORIES
News
As the Finance Forum drama entangles Westpac and Humm, here are some other ASX stocks in hot water
Health & Biotech
Weed Week: Major shifts in US legislation set to open the door for some ASX cannabis stocks
Health & Biotech
Phillip Morris mulls cannabis, pot market gets up off the couch… almost
Health & Biotech
Hot Pot Stocks: Here are 8 ASX plays that have tripled in the last 12 months
Health & Biotech
Cann Group, Emyria team up in bid to gain TGA approval for low-dose CBD gelcap
Health & Biotech
Not covered: Cann Group on the hook for $3.6 million cybersecurity incident
News
Last Orders: Stocks climb again as the ASX issues more speeding tickets
Health & Biotech
Cann Group lowers guidance, makes acquisition; Zelira to get new boss
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Cann Group gets hit by cyber attack, says it’s given a fraudster $3.6m
News
Last Orders: What you might have missed on the ASX today
Health & Biotech
Cann Group just bought some exclusive access to Europe’s biggest medicinal cannabis market
News
Last Orders: What you might have missed on the ASX today
Health & Biotech
Cannabis stocks are finishing 2020 on a high; Cann Group, Bod announce new European orders
Health & Biotech
Weed Week: All eyes on the TGA after key decision pushed back to December
News
Last Orders: What you might have missed on the ASX today
News
